RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Intersect Ent Stock

Intersect Ent Market capitalization 2024

Intersect Ent Market capitalization

939.54 M USD

Ticker

XENT

ISIN

US46071F1030

WKN

A117WV

In 2024, Intersect Ent's market cap stood at 939.54 M USD, a 57.27% increase from the 597.4 M USD market cap in the previous year.

The Intersect Ent Market capitalization history

YEARMarket Capitalization (undefined USD)
20210.77
20200.58
20190.75
20181.02
20170.7
20160.44
20150.63
20140.19
2013-
2012-

Intersect Ent Aktienanalyse

What does Intersect Ent do?

Intersect ENT Inc. is a biotechnology company specializing in the development of innovative therapies and devices for the treatment of chronic sinusitis and other nasal cavity disorders. The company was founded in 2003 and is headquartered in Menlo Park, California. The company's history began with the development of a novel implant system designed to provide effective and gentle treatment for chronic sinusitis. In 2012, the first product called PROPEL mini was launched, which serves as a two-part system for placement in the patient's sinuses. The implant ensures faster recovery after delicate surgeries and prevents adhesions. This innovation has revolutionized the way chronic sinusitis is treated. The PROPEL technology consists of a biodegradable polymer that gradually breaks down in the patient's body. It is available in various sizes and shapes to cater to the individual needs of each patient. In addition to the PROPEL technology, Intersect ENT also has other products in their portfolio targeting nasal cavity disorders. These include the SINUVA implant, used in patients with nasal polyps, as well as various devices for nasal perforation. Intersect ENT's business strategy is focused on maintaining and expanding their leadership in nasal healthcare innovation. The company heavily invests in research and development to create new products and technologies that meet medical needs and can improve patients' lives. To promote the sale of their products, Intersect ENT has built a comprehensive distribution network consisting of their own sales representatives and independent contract partners. The company collaborates closely with medical professionals and healthcare facilities to test and validate the effectiveness of their products. Intersect ENT is a company with a clear focus on innovation and excellence in product development. Their goal is to revolutionize the treatment of nasal diseases while providing patients with a better quality of life. With their groundbreaking technologies and extensive expertise, Intersect ENT has become a leading provider of nasal cavity solutions and is highly esteemed in the industry. Intersect Ent ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Intersect Ent's Market Capitalization

Intersect Ent's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Intersect Ent's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Intersect Ent's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Intersect Ent’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Intersect Ent stock

What is the current Intersect Ent market capitalization?

The current market capitalization of Intersect Ent is 939.54 M USD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Intersect Ent.

How has the market capitalization of Intersect Ent developed in recent years?

The market capitalization of Intersect Ent has increased/decreased by 57.27% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Intersect Ent?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Intersect Ent?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Intersect Ent have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Intersect Ent pay?

Over the past 12 months, Intersect Ent paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Intersect Ent is expected to pay a dividend of 0 USD.

What is the dividend yield of Intersect Ent?

The current dividend yield of Intersect Ent is .

When does Intersect Ent pay dividends?

Intersect Ent pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Intersect Ent?

Intersect Ent paid dividends every year for the past 0 years.

What is the dividend of Intersect Ent?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Intersect Ent located?

Intersect Ent is assigned to the 'Health' sector.

Wann musste ich die Aktien von Intersect Ent kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Intersect Ent from 10/10/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/10/2024.

When did Intersect Ent pay the last dividend?

The last dividend was paid out on 10/10/2024.

What was the dividend of Intersect Ent in the year 2023?

In the year 2023, Intersect Ent distributed 0 USD as dividends.

In which currency does Intersect Ent pay out the dividend?

The dividends of Intersect Ent are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Intersect Ent

Our stock analysis for Intersect Ent Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Intersect Ent Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.